SAGD Stock Overview
South American Gold Corp. is focused on becoming the premiere provider of value added products and services for the cultivation and processing of cannabis for the South American medical and recreational markets with an initial focus on the Uruguayan market.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
South American Gold Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.000001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -99.93% |
5 Year Change | -99.93% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
SAGD | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | -1.2% | -0.7% |
1Y | n/a | 15.8% | 25.9% |
Return vs Industry: Insufficient data to determine how SAGD performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how SAGD performed against the US Market.
Price Volatility
SAGD volatility | |
---|---|
SAGD Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.5% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SAGD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SAGD's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | David Reeves | https://www.sagdcorp.com/ |
South American Gold Corp. is focused on becoming the premiere provider of value added products and services for the cultivation and processing of cannabis for the South American medical and recreational markets with an initial focus on the Uruguayan market.
South American Gold Corp. Fundamentals Summary
SAGD fundamental statistics | |
---|---|
Market cap | US$1.30k |
Earnings (TTM) | -US$433.59k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs SAGD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SAGD income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$433.59k |
Earnings | -US$433.59k |
Last Reported Earnings
Sep 30, 2013
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did SAGD perform over the long term?
See historical performance and comparison